Janus Henderson Group’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$123M Buy
+4,942,732
New +$129M 0.05% 271
2026
Q1
$50.1M Sell
2,394,972
-249,265
-9% -$3.47M 0.02% 412
2025
Q4
$23.5M Buy
2,644,237
+341,963
+15% +$2.95M 0.01% 582
2025
Q3
$19.3M Buy
+2,302,274
New +$15.6M 0.01% 631
2025
Q1
– Sell
-11,631
Closed -$35.9K – 2550
2024
Q4
$35.9K Hold
11,631
– – ﹤0.01% 2521
2024
Q3
$89.6K Hold
11,631
– – ﹤0.01% 2514
2024
Q2
$100K Sell
11,631
-264
-2% -$2.04K ﹤0.01% 2500
2024
Q1
$94.8K Sell
11,895
-13
-0.1% -$139 ﹤0.01% 2511
2023
Q4
$118K Buy
11,908
+3
+0% +$26 ﹤0.01% 2514
2023
Q3
$134K Sell
11,905
-25
-0.2% -$152 ﹤0.01% 2468
2023
Q2
$39.5K Sell
11,930
-56
-0.5% -$201 ﹤0.01% 2589
2023
Q1
$47.4K Buy
+11,986
New +$69.6K ﹤0.01% 2667
2022
Q2
– Sell
-588,783
Closed -$4.44M – 2686
2022
Q1
$4.44M Buy
588,783
+51,682
+10% +$448K ﹤0.01% 1037
2021
Q4
$5.86M Buy
+537,101
New +$6.46M ﹤0.01% 1032
2021
Q3
– Sell
-56,384
Closed -$635K – 2224
2021
Q2
$635K Sell
56,384
-20,588
-27% -$231K ﹤0.01% 1401
2021
Q1
$834K Sell
76,972
-97,563
-56% -$1.12M ﹤0.01% 1286
2020
Q4
$1.99M Sell
174,535
-43,747
-20% -$461K ﹤0.01% 1124
2020
Q3
$2.31M Buy
+218,282
New +$2.23M ﹤0.01% 1036

Other funds holding TNGX

Janus Henderson Group's TNGX Position: Q3 2026 in Review

Janus Henderson Group opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 4,942,732 shares worth $123M. The stake represents 0.05% of the portfolio and ranks #271 among its holdings. This is a return to the name: Janus Henderson Group previously reported a position in TNGX as recently as Q1 2026.

Janus Henderson Group first reported a position in TNGX in Q3 2020 and has held it in 18 quarters since. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Janus Henderson Group held 4,942,732 shares of Tango Therapeutics worth $123M as of Q3 2026.
  • Tango Therapeutics was a new Janus Henderson Group position in Q3 2026.
  • Tango Therapeutics made up 0.05% of Janus Henderson Group's portfolio in Q3 2026, its #271 holding.
  • Janus Henderson Group first reported a position in Tango Therapeutics in Q3 2020 and has held it in 18 quarters since.
  • 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.